{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:24:06Z","timestamp":1776335046401,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cger.2020.12.001","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T16:14:11Z","timestamp":1616516051000},"page":"253-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Diabetes and Peripheral Nerve Disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Lindsay A.","family":"Zilliox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cger.2020.12.001_bib1","series-title":"IDF diabetes Atlas","first-page":"1","volume":"vol. 7","year":"2015"},{"key":"10.1016\/j.cger.2020.12.001_bib2","first-page":"342","article-title":"Cardiovascular autonomic neuropathy: clinical manifestations and measurement","volume":"7","author":"Ziegler","year":"1999","journal-title":"Diabetes Rev"},{"issue":"10","key":"10.1016\/j.cger.2020.12.001_bib3","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2337\/dc06-0926","article-title":"Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes","volume":"29","author":"Schofield","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cger.2020.12.001_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2","article-title":"Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM)","volume":"21","author":"Cohen","year":"1998","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.cger.2020.12.001_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.164.9.1021","article-title":"The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy","volume":"164","author":"Smith","year":"2004","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.cger.2020.12.001_bib6","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/dc11-2028","article-title":"Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study","volume":"35","author":"Bongaerts","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cger.2020.12.001_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cger.2020.12.001_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11940-005-0004-4","article-title":"Polyneuropathy with impaired glucose tolerance: implications for diagnosis and therapy","volume":"7","author":"Singleton","year":"2004","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"10.1016\/j.cger.2020.12.001_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cger.2020.12.001_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1464-5491.2004.01124.x","article-title":"Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes","volume":"21","author":"Costa","year":"2004","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.cger.2020.12.001_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.cger.2020.12.001_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/dc18-1842","article-title":"General and abdominal obesity and incident distal sensorimotor polyneuropathy: insights into inflammatory biomarkers as potential mediators in the KORA F4\/FF4 Cohort","volume":"42","author":"Schlesinger","year":"2019","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.cger.2020.12.001_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00125-019-4959-1","article-title":"New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism","volume":"62","author":"Eid","year":"2019","journal-title":"Diabetologia"},{"issue":"1\u20132","key":"10.1016\/j.cger.2020.12.001_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.06.005","article-title":"Idiopathic neuropathy patients are at high risk for metabolic syndrome","volume":"273","author":"Smith","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.cger.2020.12.001_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/B978-0-444-53480-4.00016-3","article-title":"Pathology of human diabetic neuropathy","volume":"126","author":"Malik","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"10.1016\/j.cger.2020.12.001_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1085-9489.2005.0010205.x","article-title":"Impaired peripheral nerve regeneration in diabetes mellitus","volume":"10","author":"Kennedy","year":"2005","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"9739","key":"10.1016\/j.cger.2020.12.001_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"issue":"9131","key":"10.1016\/j.cger.2020.12.001_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cger.2020.12.001_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-122-8-199504150-00001","article-title":"The effect of intensive diabetes therapy on the development and progression of neuropathy","volume":"122","author":"Group","year":"1995","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cger.2020.12.001_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.cger.2020.12.001_bib21","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/dc13-0012","article-title":"Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort","volume":"36","author":"Pop-Busui","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.cger.2020.12.001_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.cger.2020.12.001_bib23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","author":"Group","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.cger.2020.12.001_bib24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.cger.2020.12.001_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/acn3.125","article-title":"Exercise increases cutaneous nerve density in diabetic patients without neuropathy","volume":"1","author":"Singleton","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.cger.2020.12.001_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ana.24310","article-title":"Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients","volume":"77","author":"Singleton","year":"2015","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.cger.2020.12.001_bib27","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","author":"American Diabetes","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cger.2020.12.001_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jdiacomp.2012.05.007","article-title":"The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy","volume":"26","author":"Kluding","year":"2012","journal-title":"J\u00a0Diabetes Complications"},{"issue":"20","key":"10.1016\/j.cger.2020.12.001_bib29","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.cger.2020.12.001_bib30","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.cger.2020.12.001_bib31","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/dc11-0503","article-title":"Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial","volume":"34","author":"Ziegler","year":"2011","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.cger.2020.12.001_bib32","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1212\/WNL.0000000000004033","article-title":"Effect of omega-3 supplementation on neuropathy in type 1 diabetes: a 12-month pilot trial","volume":"88","author":"Lewis","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cger.2020.12.001_bib33","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.0b013e3182120147","article-title":"Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms","volume":"76","author":"Zilliox","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cger.2020.12.001_bib34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s001250050924","article-title":"The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)","volume":"41","year":"1998","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.cger.2020.12.001_bib35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.118.033990","article-title":"Erectile dysfunction as an independent predictor of future cardiovascular events: the multi-ethnic study of atherosclerosis","volume":"138","author":"Uddin","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cger.2020.12.001_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S0317167100001360","article-title":"Methylprednisolone may improve lumbosacral radiculoplexus neuropathy","volume":"28","author":"Dyck","year":"2001","journal-title":"Can J Neurol Sci"},{"issue":"Pt 1","key":"10.1016\/j.cger.2020.12.001_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/awu307","article-title":"Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes","volume":"138","author":"Gibbons","year":"2015","journal-title":"Brain"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069020300951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069020300951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:49Z","timestamp":1760061409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069020300951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0749069020300951"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2020.12.001","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and Peripheral Nerve Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}